Literature DB >> 18593526

Structures of proteases for ubiqutin and ubiquitin-like modifiers.

Byung Hak Ha1, Eunice EunKyeong Kim.   

Abstract

Post-translational modifiers can alter the function of proteins in many different ways. The conjugation of ubiquitin (Ub) and ubiqutin-like modifiers (Ubls) to proteins has been shown to be especially crucial in regulating a variety of cellular processes including the cell cycle, growth control, quality control, localization and many more. It is a highly dynamic process and involves a number of enzymes called E1, E2 and E3. Ub and Ubls are removed from the target proteins by deubiquitinating enzymes (DUBs) or Ubl-specific proteases (ULPs), thereby deconjugation can act as an additional level of control over the ubiquitin-conjugation system. In addition, DUBs and ULPs are responsible for activating Ub and Ubls from their inactive corresponding precursor forms. Here we review recent progress in molecular details of these deconjugating enzymes of Ubls.

Mesh:

Substances:

Year:  2008        PMID: 18593526     DOI: 10.5483/bmbrep.2008.41.6.435

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  11 in total

Review 1.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

2.  Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases.

Authors:  Glenn C Capodagli; Michelle K Deaton; Erica A Baker; Ryan J Lumpkin; Scott D Pegan
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

3.  Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin.

Authors:  Glenn C Capodagli; Marissa A McKercher; Erica A Baker; Emily M Masters; Joseph S Brunzelle; Scott D Pegan
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  Structure of ubiquitin-fold modifier 1-specific protease UfSP2.

Authors:  Byung Hak Ha; Young Joo Jeon; Sang Chul Shin; Kanako Tatsumi; Masaaki Komatsu; Keiji Tanaka; Christopher M Watson; Gillian Wallis; Chin Ha Chung; Eunice EunKyeong Kim
Journal:  J Biol Chem       Date:  2011-01-12       Impact factor: 5.157

Review 5.  Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.

Authors:  Yingmei Wang; Ping Ji; Jinsong Liu; Russell R Broaddus; Fengxia Xue; Wei Zhang
Journal:  Mol Cancer       Date:  2009-02-13       Impact factor: 27.401

6.  De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.

Authors:  A M Jacko; L Nan; S Li; J Tan; J Zhao; D J Kass; Y Zhao
Journal:  Cell Death Dis       Date:  2016-11-17       Impact factor: 8.469

7.  The molecular determinants for distinguishing between ubiquitin and NEDD8 by USP2.

Authors:  Yung-Cheng Shin; Jou-Han Chen; Shih-Chung Chang
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

8.  Chlamydia trachomatis-containing vacuole serves as deubiquitination platform to stabilize Mcl-1 and to interfere with host defense.

Authors:  Annette Fischer; Kelly S Harrison; Yesid Ramirez; Daniela Auer; Suvagata Roy Chowdhury; Bhupesh K Prusty; Florian Sauer; Zoe Dimond; Caroline Kisker; P Scott Hefty; Thomas Rudel
Journal:  Elife       Date:  2017-03-28       Impact factor: 8.140

9.  Insights into the regulation of intrinsically disordered proteins in the human proteome by analyzing sequence and gene expression data.

Authors:  Yvonne J K Edwards; Anna E Lobley; Melissa M Pentony; David T Jones
Journal:  Genome Biol       Date:  2009-05-11       Impact factor: 13.583

Review 10.  Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles.

Authors:  Mariola J Edelmann; Benedikt M Kessler
Journal:  Biochim Biophys Acta       Date:  2008-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.